Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessSyphilisAIDS

Independent clinic-based evaluation of dual POCTs for screening for HIV and syphilis in men who have sex with men in Italy, Malta, Peru, and the United Kingdom

BMC Infectious Diseases·

Nigel Sherriff, Massimo Mirandola, Ronaldo Silva, Maddalena Cordioli, Alexandra Sawyer, Lorenzo Gios, Antonella Zorzi, Jorg Huber, Jaime Vera, Daniel Richardson, Mohammed Hassan-Ibrahim, Dominika Wlazly, Valeska Padovese, Christopher Barbara, Anabel Darmanin, Aaron Schembri, Carlos Caceres, Silver Vargas, Karel Blondeel, James Kiarie, Firdavs Kurbonov, Rosanna W. Peeling, Soe Soe Thwin, Igor Toskin, Amina Hançali, Hicham Oumzi, Simon Mwima, Peter Kyambadde, Isaac Ssewanyana

DOI
10.1186/s12879-024-09019-3
PMID
38418941
PMCID
PMC10902927
OpenAlex
W4392770421
Study type
Meta-analysis
Publisher
Springer Science and Business Media LLC
Article type
journal-article
Integrity
current

Why this research matters now

Dual point-of-care tests could serve as a cost-effective, patient-friendly, and provider-friendly alternative to conventional testing in clinical and field settings, particularly in resource-limited environments where validated screening tools may help reduce HIV and syphilis incidence.

01

Structured evidence summary

Research question

The study evaluated the performance, acceptability, and operational characteristics of two dual point-of-care tests for HIV and syphilis screening among men who have sex with men across four countries.

Study design

Cross-sectional study enrolling 2,577 men who have sex with men at seven clinic sites. Finger prick blood was tested with point-of-care tests and compared against standard laboratory investigations on venepuncture blood. Diagnostic meta-analysis combined data from the evaluation sites.

Population and setting

Men who have sex with men presenting to seven clinic sites in Italy, Malta, Peru, and the United Kingdom.

Main findings

For the Bioline test, pooled sensitivity and specificity were 98.95% and 99.89% for HIV, and 73.79% and 99.57% for syphilis. For the Chembio test, pooled sensitivity and specificity were 98.66% and 99.55% for HIV, and 78.60% and 99.48% for syphilis. Both tests detected over 90% of probable active syphilis cases. Three-quarters of participants preferred the dual tests due to convenience, and operational characteristics were acceptable to healthcare providers.

Public-health relevance

Dual point-of-care tests could serve as a cost-effective, patient-friendly, and provider-friendly alternative to conventional testing in clinical and field settings, particularly in resource-limited environments where validated screening tools may help reduce HIV and syphilis incidence.

Important limitations

This summary is limited to the supplied single-article abstract and metadata and requires the original paper for decision-grade interpretation.

GIDS interpretation

Classifier links identify this article as relevant to AIDS and syphilis diagnostics and treatment in Italy, Malta, Peru, and the United Kingdom, supporting discovery of dual-testing literature within those disease and geographic categories.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 14 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseaddresses topicaddresses topicevaluates interventionevaluates interventionhas pathogen typehas pathogen typestudied instudied instudied instudied instudied population settingstudies pathogenuses study design